The Rosopatamab Biosimilar Anti-PSMA Antibody is a cutting-edge product designed for research in the field of prostate cancer treatment. This antibody is specifically engineered to target PSMA, a cell surface protein highly expressed in prostate cancer cells. The antibody, derived from innovative biosimilar technology, exhibits high specificity and affinity for PSMA, allowing for precise detection and analysis in experimental settings.PSMA, or prostate-specific membrane antigen, plays a crucial role in prostate cancer progression and is considered a promising therapeutic target for the development of novel cancer treatments. The Rosopatamab Antibody effectively binds to PSMA, enabling researchers to investigate its role in cancer cell proliferation, invasion, and metastasis.
This product is validated for use in various research applications, including immunohistochemistry and flow cytometry, providing valuable insights into the biology of prostate cancer.With its superior performance and accuracy, the Rosopatamab Biosimilar Anti-PSMA Antibody is a valuable tool for scientists and clinicians working towards improving diagnosis and treatment strategies for prostate cancer. Its potential impact on the development of targeted therapies and personalized medicine makes it an essential component of cutting-edge research in oncology.
Product Name:
Rosopatamab (Anti-PSMA) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0114
Target:
PSMA
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
J-591, MLN-591, huJ-591
Description:
Anti-PSMA(rosopatamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
